Sign inJoin waitlistJoin the waitlist

SS

Shimoli Shah

Cardiovascular Disease

Credentials: · · · · ·

History

Cardiovascular Disease
Washington University in St Louis
2009–2012
Internal Medicine
2006–2009
New York University Grossman School of Medicine
2002–2006

Research

Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation
Circulation · 2011 · First of 2 authors · 266 citations
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
The Lancet · 2024 · 170 citations
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Nephrology · 2025 · 56 citations

Katherine Tuttle
7 papers
AS
Arnold Silva
4 papers
Maria Caramori
4 papers
Brian Gage
2 papers
MF
Maros Ferencik
2 papers
AK
Abigail Khan
1 paper
AY
Ali Yusuf
1 paper
Andrew Oehler
1 paper · 1 as a resident
Brian Ghoshhajra
1 paper
Chadi Ayoub
1 paper
Charles Eby
1 paper
Cody Eslinger
1 paper · 1 as a resident